Federated Hermes
AGN

Federated Hermes’s Allergan plc AGN Stock Holding History

Federated Hermes’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-8,000
Closed -$1.95M – 2218
2017
Q2 		$1.95M Hold
8,000
– – 0.01% 928
2017
Q1 		$1.91M Sell
8,000
-4,000
-33% -$932K 0.01% 931
2016
Q4 		$2.31M Buy
+12,000
New +$2.49M 0.01% 814

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Federated Hermes's AGN Position: Q2 2020 in Review

Federated Hermes sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 15,318 shares — an estimated $2.71M sold.

Federated Hermes first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $176M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Federated Hermes reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Federated Hermes sold 15,318 Allergan plc shares in Q2 2020, an estimated $2.71M.
  • Federated Hermes first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Federated Hermes's Allergan plc position peaked at $176M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Federated Hermes's 13F filing for Q2 2020, filed 13 Aug 2020.